Internal Medicine, Hematology & Oncology · Fresno, CA
NPI
1578761656
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2335 E Kashian Ln, Suite 301
Fresno, CA, 93701
Phone (559) 256-9680
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$851K
483 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Ellie E Chan prescribed most often to Medicare patients was Ondansetron Hcl, with 49 prescriptions and refills. In total Ellie E Chan wrote 483 Medicare prescriptions that cost $851K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-01-10.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Ondansetron Hcl Generic | 49 | 49 | 24 | $396 |
| Hydroxyurea Generic | 38 | 102 | 12 | $1,319 |
| Nivestym Filgrastim-Aafi | 33 | 33 | 11 | $33K |
| Dexamethasone Generic | 32 | 34 | 21 | $584 |
| Anastrozole Generic | 27 | 81 | 14 | $759 |
| Granix Tbo-Filgrastim | 22 | 22 | Under 11 | $12K |
| Gabapentin Generic | 21 | 28 | Under 11 | $368 |
| Potassium Chloride Generic | 18 | 22 | Under 11 | $268 |
| Prochlorperazine Maleate Generic | 16 | 16 | Under 11 | $228 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 14 | 14 | Under 11 | $454 |
| Imbruvica Ibrutinib | 12 | 12 | Under 11 | $76K |
| Lynparza Olaparib | 12 | 12 | Under 11 | $201K |
| Retevmo Selpercatinib | 12 | 12 | Under 11 | $296K |
| Gefitinib Generic | 12 | 12 | Under 11 | $21K |
| Prednisone Generic | 11 | 23 | Under 11 | $106 |
Brand drugs: 112 claims; generic drugs: 371 claims; opioid claims: 24.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Ellie E Chan were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.